ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea · Delayed Price · Currency is KRW 123,600
+4,400 (3.69%)
Jul 10, 2026, 3:30 PM KST
ST Pharm Market Cap
ST Pharm has a market cap or net worth of 2.58 trillion as of July 10, 2026. Its market cap has increased by 61.84% in one year.
Market Cap
2.58T
Enterprise Value
2.45T
Revenue
346.22B
Ranking
n/a
PE Ratio
37.31
Stock Price
123,600.00
Market Cap Chart
Since June 23, 2016, ST Pharm's market cap has increased from 902.04B to 2.58T, an increase of 186.00%. That is a compound annual growth rate of 11.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 2.58T | 4.55% |
| Dec 30, 2025 | 2.47T | 37.85% |
| Dec 30, 2024 | 1.79T | 40.37% |
| Dec 28, 2023 | 1.28T | -22.60% |
| Dec 29, 2022 | 1.65T | -36.55% |
| Dec 30, 2021 | 2.60T | 34.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.58T |
| Celltrion | 40.18T |
| ALTEOGEN | 17.35T |
| Samsung Epis Holdings | 9.57T |
| Voronoi | 2.99T |
| Hanall Biopharma | 2.92T |
| SK bioscience | 2.88T |
| Peptron | 2.60T |